Fermion Oy is a Manufacturer/Innovator company operating in the pharmaceutical industry.
Fermion develops, manufactures and markets active pharmaceutical ingredients (APIs) to companies in global generic market as well as under exclusive contracts to companies focusing on new chemical entities (NCEs). Fermion is fully owned subsidiary of Orion Corporation and headquartered in Espoo, Finland. Together with Orion we are a fully integrated contract development and manufacturing organization (CDMO) and offer services covering both drug substances and drug products. All contract manufacturing services of Orion Group are marketed by Fermion.
Company type
Manufacturer/Innovator
Products and services
Custom Manufacturing, APIs (Active Pharmaceutical Ingredients), Contract Services – Analytical & Lab Services
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
Fermion Oy, Koivu-Mankkaan tie 6 A, P.O. Box 28, Espoo, Finland, 2200